Skip to main content
. Author manuscript; available in PMC: 2012 Sep 6.
Published in final edited form as: Thromb Haemost. 2012 Jul 26;108(3):561–569. doi: 10.1160/TH12-03-0159

Table 2.

End point results

Characteristic SOC Arm PerMIT Arm P
Time to first stable therapeutic INR (days) 8.3 (3.5–17.5) 4.7 (3.5–8) 0.0152
Therapeutic INR by day 5, % 38.5 69.2 0.1156
Therapeutic INR by day 8, % 61.5 100 0.0128
Time within therapeutic range, first 25 days, % 55.3 ± 16.6 63.4 ± 15.8 0.1805
Time within therapeutic range, first 60 days, % 70.3 ± 17.9 77.7 ± 11.3 0.441
Dose adjustments per INR measurement, % 57.1 ± 10.9 38.3 ± 8.50 0.007
INR > 3.2, % 18.5 18.5 1